AU Patent

AU2023250379A1 — Auto-injector system.

Assigned to Meridian Medical Technologies LLC · Expires 2024-10-24 · 2y expired

What this patent protects

Systems and methods for automatically reconstituting a drug and then administering it to a patient are provided. The system and methods may include a reconstitution auto-injector having a first chamber having a powder contained therein, a second chamber having a liquid contained …

USPTO Abstract

Systems and methods for automatically reconstituting a drug and then administering it to a patient are provided. The system and methods may include a reconstitution auto-injector having a first chamber having a powder contained therein, a second chamber having a liquid contained therein, a first power source, and a second power source. The first power source may be activated to compress the liquid to flow into the first chamber with the powder. The second power source may activate to inject the reconstituted drug into the patient.

Drugs covered by this patent

Patent Metadata

Patent number
AU2023250379A1
Jurisdiction
AU
Classification
—
Expires
2024-10-24
Drug substance claim
No
Drug product claim
No
Assignee
Meridian Medical Technologies LLC
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.